Regular Thyroid Screening Recommended for People With Hepatitis C
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.
Hepatitis
Top November & December 2021 FDA Approvals
November and December 2021 FDA drug approvals include treatments for hepatitis B, achondroplasia, cancer, and polycythemia vera.
Hepatitis B Shots Advised for All US Adults Younger Than 60 Years
Until now, the shots were recommended only for certain groups of adults.
Medication Treatments Lacking for Active Opioid Use Disorder in Veterans With Cirrhosis
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
Challenges in Managing Increasing Infection Rates in Cirrhosis
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Sleep-Wake Disturbance Highly Prevalent in Populations With Liver Disease
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Pharmacotherapies for Liver Fibrosis, NASH Resolution Ranked
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
Opioid Agonist Therapy Linked to Increased HCV Treatment Rates in People Who Inject Drugs
Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.
Acute-on-Chronic Liver Failure: Comparing First-Line Antivirals in Chronic HBV
Investigators conducted an ongoing prospective cohort study to better understand the safety and efficacy of nucleoside and/or nucleotide analogs among patients with hepatitis B virus-related acute-on-chronic liver failure.
Seroclearance of Hepatitis B Surface Antigens by 10 Years Rare After Antiviral Therapies
Investigators estimated the incidence of HBsAg seroclearance in patients with hepatitis B virus infection on long-term therapy with entecavir or tenofovir disoproxil fumarate.
- Loading...
Loading...
Next post in Hepatology Information Center
Loading... 
Loading...